Effect of Medical Treatment on Longitudinal Function of the Heart

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

The purpose of this study is to determine the effect of medical treatment on longitudinal myocardial function. Patients who have been hospitalized for reasons other than heart disease will be examined with Transthoracic Cardiography before and after medical treatment to determine change in myocardial function.

See also
	Status	Clinical Trial	Phase
	Unknown status	`NCT01254253` - Functional and Clinical Benefits of PCI in Patients With CTO	N/A

NCT number	NCT02237794
Study type	Observational
Source	Hillel Yaffe Medical Center
Contact	Said Younis, MD
Phone	972-5-446-66274
Email	saidjy@gmail.com
Status	Not yet recruiting
Phase	N/A
Start date	October 2014
Completion date	October 2016

Effect of Medical Treatment on Longitudinal Function of the Heart

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms